Many excellent points by mojoey in this thread; I would like to expand on some specific parameters of performance for which we need to be able to hold the CFIDS Association accountable; perhaps these will provide some necessary clarification to the community of the Association's stance and viewpoints, and also help us develop benchmarks for its performance in both its research and advocacy capacities.
The CAA must be accountable not only for economic return of investment in the abstract, but for the impact on patients and their families of the research definitions it employs, the specific philosophical direction of that research, the literature it puts out, and of its past and future attempts to educate the medical community (such as online courses for doctors, the last one being in key areas both uninformed and potentially harmful in its embrace of unfalsifiable and otherwise scientifically questionable psychological and rehabilitative concepts).
Given that Suzanne Vernon, their Science Director, was a co-author of the CDC's deeply flawed "Empirical Definition" for CFS, and given her favorable references to psychosomatic interpretations of CFS in a past research network proposal (discussed elswehere on this forum) and past research collaborations with CDC scientists who have consistently psychologized our illness, the CAA has a responsibility to provide a clear statement from Dr. Vernon explaining her views on the role of psychological factors in creating or perpetuating any of the symptomology of CFS. This should include her own, and the Association's, view on "kinesiophobia", or fear or activity, which the CAA's Medscape CME attributed to many CFS patients. It should also include her current view on the utility of the "Empirical Definition" of CFS, taking into consideration the many criticisms levelled against it (most prominently by Leonard Jason) and her assessment of her own role in creating it.
Given that the CAA has consistently promoted CBT/GET and even an article (quickly pulled after criticism on this forum, by the way) by Alex Howard which clearly stated just part of his views of psychological causation of CFS, the CAA has a responsibility to provide a clear position statement on (1) the role of psychological factors in creating or perpetuating any of the symptomology of CFS, (2) CBT, the Lightning Process and other "mind/body" treatments offered for CFS; (3) whether treatments/ therapies with limited or zero scientific validation or basis will be promoted (including being described in uncritical pieces) in any way by the Association; (4) the Association's method for determining the merit of treatments or therapies it will actually endorse, especially CBT and GET, including whether that method will incorporate thorough analyses of objective research and patient surveys on the efficacies of these therapies that make them worthy of such an endorsement to the patient community and to our doctors.
Given that the CAA has consistently promoted GET and related forms of gradual exercise increase for patients - sometimes on the advice of a few consulting physicians whose views are not universal among ME/CFS specialists - the CAA has a responsibility to provide a clear position statement of activity and exercise recommendations in ME/CFS that addresses the concerns of clinicians and patients whose experience contradicts that of those who endorse GET/ exercise in general for people with ME/CFS. This position statement must include a scientific justification for this position, and an analysis of all relevant research findings on the subject - not just those that find GET beneficial.
Given the questionable material the CAA has presented in the past regarding severely ill ME/CFS patients, or the general lack of information and focus on such patients at all, and given that these patients represent a significant but grieviously underreported percentage of the patient population, the CAA has a responsibility to (1) investigate and document the epidemiology, clinical description, and unique needs of this population - something that has been done in the UK but not in the US, (2) provide more information and focus on this group for the patients, their families, and especially for clinicians, so that the segment of the community most vulnerable to physical damage receives some degree of protection and advocacy; (3) re-examine the Association's promoted literature/ guidelines to clinicians to ensure that it is adjusted to unambiguously document the often unique limitations of this group of ME/CFS patients.
I would also argue that the CAA, as an organization soliciting funds for a research program, should clearly state guiding hypotheses of that program, including its current model or models of ME/CFS causation and pathophysiology that inform the development of its research program, and upon which the selection of studies to fund is based. Given past and especially recent advancements in ME/CFS research, the relative role of pathogens in those hypotheses/ models, and the degree to which the research program as a whole is or is not guided by a search for clues to pathogen involvement, should be unequivocally stated. Last but by no means least, the degree of the Associations's commitment to clear clinical and research definitions of ME/CFS should be stated. Any research funded by the Association should be required to incorporate use of the Canadian Consensus guidelines (adapted appropriately for research purposes).